Skip to main content
See every side of every news story
Published • loading... • Updated

Novartis Says AI Is Speeding Drug Discovery and Trials, but Clinical Payoff Remains Unproven

Summary by MarketBeat
Novartis (NYSE:NVS) is applying artificial intelligence across drug research and clinical development, with executives reporting faster trial enrollment and drug candidate selection while cautioning that evidence of improved clinical success will take longer to emerge. At an investor event, company

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Thursday, November 19, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal